CD19-targeting CAR T cells protect from ANCA-induced acute kidney injuryDörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
5 January 2024
Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritisFernanda Gutierrez-Rodrigues, Kristina V Wells, Adrianna I Jones, Dalton Hironaka, Cameron Rankin, Massimo Gadina, Keith A Sikora, Lemlem Alemu, Rodrigo T Calado, Kaitlin A Quinn, Bhavisha Patel, Neal S Young, Peter C Grayson
29 November 2023
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathwaysDimitris Veroutis, Ourania D Argyropoulou, Andreas V Goules, Konstantinos Kambas, Dimitris Anastasios Palamidas, Konstantinos Evangelou, Sophia Havaki, Aikaterini Polyzou, Dimitrios Valakos, Evangelia Xingi, Elli Karatza, Kyriaki A Boki, Alberto Cavazza, Christos Kittas, Dimitris ThanosSee the full list of authors
24 November 2023
Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumaticaEugenio De Miguel, Rositsa Karalilova, Pierluigi Macchioni, Cristina Ponte, Edoardo Conticini, Sharon Cowley, Alessandro Tomelleri, Sara Monti, Irene Monjo, Zguro Batalov, Giulia Klinowski, Paolo Falsetti, David J Kane, Corrado Campochiaro, Alojzija Hočevar
6 November 2023
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trialReza Zonozi, Frank B Cortazar, Anushya Jeyabalan, Gabriel Sauvage, Pravarut Nithagon, Noah R Huizenga, Jillian M Rosenthal, Alexander Sipilief, Katherine Cosgrove, Karen A Laliberte, Eugene P Rhee, William F Pendergraft, III, John L Niles
11 December 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, Christian Pagnoux, Antoine Néel, Pascal Cohen, Olivier Aumaître, Stanislas Faguer, Pierre Gobert, François Maurier, Maxime Samson, Pascal Godmer, Bernard Bonnotte, Vincent Cottin, Catherine Hanrotel-SaliouSee the full list of authors
2 November 2023
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trialDuvuru Geetha, Anisha Dua, Huibin Yue, Jason Springer, Carlo Salvarani, David Jayne, Peter Merkel, , ADVOCATE Study Group, C. Au Peh, A. Chakera, B. Cooper, J. Kurtkoti, D. Langguth, V. LevidiotisSee the full list of authors
18 November 2023
Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide databaseYuichi Ishikawa, Kei Tokutsu, Shingo Nakayamada, Aya Kuchiba, Kiyohide Fushimi, Shinya Matsuda, Yoshiya Tanaka
19 September 2023
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up studyShunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-ichiro KagamiSee the full list of authors
21 September 2023
Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated queryingKarl Gisslander, Matthew Rutherford, Louis Aslett, Neil Basu, François Dradin, Lucy Hederman, Zdenka Hruskova, Hicham Kardaoui, Peter Lamprecht, Sabina Lichołai, Jacek Musial, Declan O’Sullivan, Xavier Puechal, Jennifer Scott, Mårten SegelmarkSee the full list of authors
31 October 2023